What to Do About Injection Site Reactions
Injection site reactions are a common concern for anyone using injectable GLP‑1 medications such as semaglutide or tirzepatide for weight management.
Key Takeaways
- Most injection site reactions are mild, short‑lived, and not a sign of serious harm.
- Proper injection technique and site rotation are the most effective ways to prevent irritation.
Common Signs and Symptoms
Redness, swelling, itching, bruising, or a small lump at the injection point usually resolve within a day or two.
How to Reduce the Risk
Rotate injection sites, use the correct needle length, clean the skin, warm the medication, and inject at a 90‑degree angle.
What to Do If You Experience a Reaction
Apply a cool compress, gently massage the area, use topical soothing agents sparingly, and document the reaction.
When to Seek Medical Help
Spreading redness, warmth or pus, fever, or a persistent lump should prompt a call to a provider.
Closing Thoughts
Injection site reactions are usually minor and manageable with proper technique, simple home care, and timely medical guidance when needed.
See if you qualify for a GLP-1 prescription online
Get matched with a licensed provider for a quick online consultation. (Sponsored — we may earn a commission.)
Sources
- FDA Prescribing Information
- National Institutes of Health (NIH)
- peer-reviewed clinical trials such as STEP